Fueled by a two-year, $460,000 grant by the Leukemia and Lymphoma Society, the world’s largest advocacy organization for patients with blood cancers, Sylvester is conducting one of the first studies of its kind to evaluate the society’s impact on patient outcomes.

An accomplished research team led by Frank J. Penedo, Ph.D., is spearheading the research that includes other NCI-designated cancer centers also dedicated to assessing the society’s impact on patients’ access to care, quality of life, and financial burden. They also will assess if the effects of its services and programs vary by such things as patient age, race/ethnicity, education, and insurance.